To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
A collaboration between researchers of the Yamanashi University (Japan) and the CEA showed that it is possible to characterize liver lesions from their elastic properties estimated virtually from MRI measurements of the molecular diffusion of the water. The MRI is thus an interesting option to succeed the conventional MRI elastography used in these exams, the latter with defects (low resolution images, heavy implementation). This work was published in the journal Radiology on June 12, 2017.
A Research Team of the SHFJ (LDM-TEP) has just developed an innovative radiopharmaceutical for lymphoproliferative diseases, [18F] Fludarabine.
A SIMOPRO Research Team has characterized a green mamba venom toxin, mambaquetine, which is proving to be a very promising therapeutic candidate for the fight against polycystic kidney disease, a genetic disorder that causes cysts in kidneys
Got it ! Thursday, the 18th of May 2017, at 9:30 pm, the 11.7 Tesla magnet of the Iseult project joined the CEA, after a journey started on the 4th of May in Belfort, to be installed at NeuroSpin.
The free project PIWS is developed by NeuroSpin. It allows to assemble and serve the data of major European / international projects in population imaging for big-data analyzes. PIWS relies on CubicWeb, a semantic web software developed by the French company Logilab.
A team from the CEA Frédéric-Joliot Institute has developed new optical probes for non-invasive imaging. These chemical tools could lead to the development of diagnostic agents to better characterize the risk of aortic aneurysm.
After its creation by Michel Léonetti, a researcher at SPI / LERI, and Luc Boblet, external holder at the CEA, backed by the IDEX Paris-Saclay funding among other things, the H-Immune start-up recently signed a partnership agreement with the Pierre Fabre Innovation Fund to develop cancer immunotherapy treatments.
On Thursday, May 4, a giant magnet weighing 130 metric tons will leave the assembly plants in Belfort on its journey to the NeuroSpin research facility at the CEA's Paris-Saclay Center (Essonne).
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.